WPP
CVS icon

Whalerock Point Partners’s CVS Health CVS Stock Holding History

Whalerock Point Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$427K Hold
5,950
– – 0.08% 133
2025
Q4 		$472K Sell
5,950
-405
-6% -$31.9K 0.09% 124
2025
Q3 		$479K Hold
6,355
– – 0.1% 111
2025
Q2 		$438K Buy
6,355
+300
+5% +$19.7K 0.09% 122
2025
Q1 		$410K Buy
6,055
+1,207
+25% +$72.2K 0.1% 118
2024
Q4 		$218K Sell
4,848
-200
-4% -$11.2K 0.05% 178
2024
Q3 		$317K Sell
5,048
-138
-3% -$8.05K 0.08% 142
2024
Q2 		$306K Sell
5,186
-243
-4% -$15.2K 0.08% 123
2024
Q1 		$433K Sell
5,429
-5,507
-50% -$421K 0.12% 116
2023
Q4 		$864K Sell
10,936
-885
-7% -$63K 0.27% 66
2023
Q3 		$825K Sell
11,821
-827
-7% -$58.6K 0.29% 62
2023
Q2 		$874K Sell
12,648
-1,397
-10% -$99.4K 0.3% 61
2023
Q1 		$1.04M Buy
14,045
+1,540
+12% +$129K 0.39% 54
2022
Q4 		$1.17M Buy
12,505
+107
+0.9% +$10.3K 0.47% 47
2022
Q3 		$1.18M Buy
12,398
+760
+7% +$75.2K 0.52% 48
2022
Q2 		$1.08M Buy
11,638
+250
+2% +$24.4K 0.46% 49
2022
Q1 		$1.15M Buy
11,388
+350
+3% +$36.8K 0.41% 50
2021
Q4 		$1.14M Buy
11,038
+296
+3% +$27.4K 0.39% 52
2021
Q3 		$912K Buy
10,742
+350
+3% +$29.3K 0.35% 58
2021
Q2 		$867K Buy
10,392
+275
+3% +$22.5K 0.33% 61
2021
Q1 		$761K Sell
10,117
-1,317
-12% -$95.9K 0.33% 60
2020
Q4 		$781K Buy
11,434
+10,625
+1,313% +$691K 0.37% 58
2020
Q3 		$809K Sell
809
-13,951
-95% -$868K 0.45% 55
2020
Q2 		$959K Sell
14,760
-2,336
-14% -$147K 0.57% 46
2020
Q1 		$1.01M Sell
17,096
-6,200
-27% -$414K 0.73% 44
2019
Q4 		$1.73M Sell
23,296
-1,858
-7% -$130K 0.92% 33
2019
Q3 		$1.59M Buy
25,154
+611
+2% +$36.2K 0.85% 33
2019
Q2 		$1.34M Sell
24,543
-25
-0.1% -$1.35K 0.76% 36
2019
Q1 		$1.32M Buy
24,568
+4,651
+23% +$287K 0.87% 37
2018
Q4 		$1.3M Sell
19,917
-1,965
-9% -$147K 1.21% 24
2018
Q3 		$1.72M Hold
21,882
– – 1.25% 25
2018
Q2 		$1.41M Sell
21,882
-4,850
-18% -$320K 1.12% 26
2018
Q1 		$1.66M Sell
26,732
-1,319
-5% -$94.6K 0.53% 39
2017
Q4 		$2.03M Sell
28,051
-6,150
-18% -$447K 0.64% 30
2017
Q3 		$2.78M Sell
34,201
-1,475
-4% -$117K 0.98% 17
2017
Q2 		$2.87M Sell
35,676
-1,216
-3% -$96K 1.05% 14
2017
Q1 		$2.9M Sell
36,892
-398
-1% -$31.8K 1.08% 18
2016
Q4 		$2.94M Sell
37,290
-1,036
-3% -$83.8K 1.16% 18
2016
Q3 		$3.41M Buy
+38,326
New +$3.62M 1.41% 15
2016
Q1 		$3.79M Sell
36,525
-1,824
-5% -$177K 1.63% 12
2015
Q4 		$3.75M Buy
38,349
+6,185
+19% +$606K 1.63% 12
2015
Q3 		$3.1M Buy
32,164
+2,235
+7% +$235K 1.34% 14
2015
Q2 		$3.14M Buy
29,929
+1,700
+6% +$174K 1.3% 14
2015
Q1 		$2.91M Buy
28,229
+465
+2% +$47.1K 1.19% 14
2014
Q4 		$2.67M Buy
27,764
+2,880
+12% +$254K 1.13% 18
2014
Q3 		$1.98M Buy
24,884
+350
+1% +$27.6K 0.89% 25
2014
Q2 		$1.85M Buy
24,534
+3,745
+18% +$283K 0.88% 25
2014
Q1 		$1.56M Buy
20,789
+6,400
+44% +$452K 0.79% 26
2013
Q4 		$1.03M Buy
+14,389
New +$925K 0.54% 36

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Whalerock Point Partners's CVS Position: Q1 2026 in Review

Whalerock Point Partners held its CVS Health (CVS) position steady in Q1 2026 at 5,950 shares worth $427K. The position accounts for 0.08% of the portfolio, ranked #133.

Whalerock Point Partners first reported a position in CVS in Q4 2013 and has held it in 49 quarters since. The position peaked at $3.79M in Q1 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Whalerock Point Partners held 5,950 shares of CVS Health worth $427K as of Q1 2026.
  • Whalerock Point Partners left its CVS Health share count unchanged in Q1 2026.
  • CVS Health made up 0.08% of Whalerock Point Partners's portfolio in Q1 2026, its #133 holding.
  • Whalerock Point Partners first reported a position in CVS Health in Q4 2013 and has held it in 49 quarters since.
  • Whalerock Point Partners's CVS Health position peaked at $3.79M in Q1 2016.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Whalerock Point Partners's 13F filing for Q1 2026, filed 15 May 2026.